Press Releases
January 1, 2006
Xanodyne Pharmaceuticals Recruits Second Sales Force to Address Pain Markets
Newport, KY – Xanodyne Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management, today announced that it has completed the recruitment of a second sales force to address pain markets. Initially comprising six sales specialists, the new sales force will be promoting Oramorph SR ® to high prescribers of morphine and other pain medications. This new sales force will complement and work alongside our existing 65 member field sales force which calls on OB/GYNs.
“This is our first step towards building a franchise in pain management at Xanodyne. With Oramorph SR®, we have an opportunity to build relationships and understanding with prescribers of pain medications which will be of benefit when we are ready to launch the three exciting pain products in our development pipeline. ” said Dan Docherty, Vice President of Sales at Xanodyne.
About Xanodyne
Xanodyne Pharmaceuticals, Inc. is a privately owned, fully integrated, branded specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management. The company, located in the greater Cincinnati area, has a nationwide sales force and currently markets numerous pharmaceutical products. More information regarding Xanodyne can be accessed at www.xanodyne.com.
###